Retia Medical, LLC is a digital health company that aims to improve guided care of critically ill patients in the operating room and intensive care unit.
The Argos® Hemodynamic Monitor was developed by industry-leading experts in physiology, signal processing and algorithm development and backed by over 15 years of research. The Argos® is more consistently accurate, easier-to-use and more affordable than competing options, enabling critical care teams to make confident, data-driven decisions to enhance the guided care of all their highest risk patients
The Argos Hemodynamic Monitor has both FDA 510(k) and the CE Mark. The top five hospitals in the United States and several other leading academic medical centers have purchased and used the Argos monitor to help guide care for thousands of patients in 14 countries worldwide. Our headquarters are in Valhalla, New York.